ClinConnect ClinConnect Logo
Search / Trial NCT06474702

Predicting Violent Outburst in Inpatient Pediatric Psychiatry Ward Using a Wearable Device.

Launched by SHEBA MEDICAL CENTER · Jun 23, 2024

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at how a special wearable device can help predict aggressive behavior and violent outbursts in children under 12 years old who are being treated in a psychiatric hospital. The goal is to use the information collected from the device to better understand when these outbursts might happen, which could help caregivers and doctors keep the children safe and manage their care more effectively.

To be eligible for this trial, children must be under the age of 13 and have a mental disorder that requires hospitalization at the Edmond and Lily Safra Children's Hospital in Israel during 2024. However, children who have allergies to the device material, are very sensitive to wearing it, or do not show any aggressive behavior will not be included. For those who participate, they will wear the device, which is non-invasive and designed to be comfortable, while their behavior is monitored. This study is still in the planning stages and is not yet recruiting participants.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • the investigator will include patients under the age of 13 with various mental disorders admitted to our inpatient psychiatry ward at 'Edmond and Lily Safra' Children's Hospital, Sheba Medical Centre, Tel Hashomer, Ramat Gan, Israel during 2024.
  • Exclusion Criteria:
  • the investigator will exclude patients that were hospitalized but did not want to participate, or couldn't participate due to increased sensorial sensitive to the device. the investigator will exclude patients with no violence outburst or aggressive attitude that were hospitalized at our inpatient psychiatric ward during 2024. additional, patients who suffers dermatological illnesses and might show allergic reactions to the device material on their wrist will be excluded.

About Sheba Medical Center

Sheba Medical Center, located in Israel, is a leading academic medical institution renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent clinical trial sponsor, Sheba Medical Center leverages its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies aimed at improving patient outcomes and developing novel therapeutic interventions. The center's collaborative environment fosters partnerships with global research organizations, enhancing its ability to contribute to the scientific community and drive medical advancements across various fields. With a strong focus on patient safety and ethical standards, Sheba Medical Center is dedicated to translating research findings into practical applications that benefit patients worldwide.

Locations

Patients applied

0 patients applied

Trial Officials

Doron Gothelf, M.D

Principal Investigator

Sheba Medical Center

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported